Prostatic involvement in bladder cancer. Prostate mapping in 20 cystoprostatectomy specimens.

Area of Science:

• Urologic Oncology
• Surgical Pathology

Background:

• High-grade bladder cancer, including papillary tumors and carcinoma in situ, poses significant treatment challenges.
• The prostate gland's proximity to the bladder raises questions about potential cancer spread.
• Understanding patterns of urothelial carcinoma spread is crucial for effective patient management.

Purpose of the Study:

• To investigate the histological extent and pattern of prostatic duct involvement by urothelial carcinoma in patients undergoing cystoprostatectomy.
• To determine the clinical significance of prostatic involvement in high-grade bladder cancer.
• To evaluate the potential for intraepithelial permeation as a route of cancer spread into the prostate.

Main Methods:

• Histological mapping of 20 prostate glands from patients with high-grade bladder tumors or carcinoma in situ.
• Detailed examination of prostatic ducts for urothelial carcinoma infiltration.
• Correlation of prostatic findings with bladder cancer characteristics.

Main Results:

• Nine of twenty patients showed urothelial carcinoma involvement within prostatic ducts.
• Seven patients had focal involvement in periurethral ducts; two had extensive involvement.
• Intraepithelial permeation was the primary mechanism of cancer spread into the prostate.
• Prostatic involvement was clinically silent in all affected patients.
• Fourteen incidental occult prostatic adenocarcinomas were also identified.

Conclusions:

• Clinically silent urothelial carcinoma involvement of the prostate occurs in a significant subset of patients with high-grade bladder cancer.
• This prostatic involvement may represent a source of treatment failure for conservative therapies.
• Routine transurethral prostatic biopsy may be beneficial in the workup of patients with carcinoma in situ and high-grade bladder cancer.